Bearish
Kidney drug developer XORTX prices US$5M Nasdaq share sale
XORTX Therapeutics has priced a public offering of 2,659,574 common shares or pre-funded warrants at US$1.88 per share, aiming to raise US$5 million i...
XRTX
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (1)
Latest XRTX News
Bearish
Neutral
[EFFECT] XORTX Therapeutics Inc. SEC Filing
XORTX Therapeutics Inc. filed an EFFECT Form with the SEC, which became effective on May 13, 2026. This filing, with accession number 0001104659-26-05...
Research XRTX on:
Ad Space